BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND BCL10, CIPER, 8915, ENSG00000142867, c-E10, CARMEN, mE10, CLAP
13 results:

  • 1. Multiparametric immune profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: an exploratory study of the clap trial.
    Wang Y; Lai Y; Peng H; Yan S; Liu Z; Tong C; Huang X
    Clin Transl Oncol; 2023 Jan; 25(1):256-268. PubMed ID: 36115931
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Fisetin Deters Cell Proliferation, Induces Apoptosis, Alleviates Oxidative Stress and Inflammation in Human cancer Cells, HeLa.
    Afroze N; Pramodh S; Shafarin J; Bajbouj K; Hamad M; Sundaram MK; Haque S; Hussain A
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163629
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. bcl10 correlates with bad prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.
    Chen H; Li Z; Wu F; Ji W; Lu L; Wu Z; Huang Y; Wang W; Li S
    IUBMB Life; 2023 Mar; 75(3):207-224. PubMed ID: 34928543
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the clap trial.
    Huang X; He M; Peng H; Tong C; Liu Z; Zhang X; Shao Y; Zhu D; Zhang J; Yin JC; Yang F; Lan C
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34011535
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Camrelizumab Plus Apatinib in Patients With Advanced cervical cancer (clap): A Multicenter, Open-Label, Single-Arm, Phase II Trial.
    Lan C; Shen J; Wang Y; Li J; Liu Z; He M; Cao X; Ling J; Huang J; Zheng M; Zou G; Yan H; Liu Q; Yang F; Wei W; Deng Y; Xiong Y; Huang X
    J Clin Oncol; 2020 Dec; 38(34):4095-4106. PubMed ID: 33052760
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prevalence of HPV-16/18 genotypes and immediate histopathologic correlation results in a Chinese population with negative cytology and positive high-risk HPV testing.
    Tao X; Zhang H; Li J; Zhang H; Xiao J; Zhang L; Zhou X; Sui L; Wang L; Zhao C
    Cancer Cytopathol; 2019 Oct; 127(10):650-657. PubMed ID: 31532582
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. bcl10 crucially nucleates the pro-apoptotic complexes comprising PDK1, PKCζ and caspase-3 at the nuclear envelope of etoposide-treated human cervical carcinoma C4-I cells.
    Chiarini A; Liu D; Armato U; Dal Prà I
    Int J Mol Med; 2015 Sep; 36(3):845-56. PubMed ID: 26202083
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Folic acid conjugated cross-linked acrylic polymer (FA-clap) hydrogel for site specific delivery of hydrophobic drugs to cancer cells.
    Pillai JJ; Thulasidasan AK; Anto RJ; Chithralekha DN; Narayanan A; Kumar GS
    J Nanobiotechnology; 2014 Jul; 12():25. PubMed ID: 25026938
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Role-shifting PKCζ fosters its own proapoptotic destruction by complexing with bcl10 at the nuclear envelope of human cervical carcinoma cells: a proteomic and biochemical study.
    Chiarini A; Marconi M; Pacchiana R; Dal Prà I; Wu J; Armato U
    J Proteome Res; 2012 Aug; 11(8):3996-4012. PubMed ID: 22812606
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Expression of bcl10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB-dependent cyclin D1 signaling.
    Kuo SH; Chou CH; Cheng AL; Wang CW; Chen YH; Chen RJ
    Gynecol Oncol; 2012 Aug; 126(2):245-51. PubMed ID: 22564715
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Clinicopathologic characteristics and chromosomal abnormalities in salivary mucosa associated lymphoid tissue lymphomas].
    Li BZ; Yu CJ; Xu JJ; Lu HF; Shi DR
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Aug; 44(8):651-6. PubMed ID: 19961773
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. HIV infection in women: perinatal issues and cervical cancer surveillance.
    Zorrilla CD
    Top HIV Med; 2007; 15(1):1-5. PubMed ID: 17406077
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. bcl10 is not a target for frequent mutation in human carcinomas.
    Lambers AR; Gumbs C; Ali S; Marks JR; Iglehart JD; Berchuck A; Futreal PA
    Br J Cancer; 1999 Jul; 80(10):1575-6. PubMed ID: 10408401
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.